Synaptopathies: diseases of the synaptome

[1]  Joseph T. Glessner,et al.  Rare Copy Number Variants in Tourette Syndrome Disrupt Genes in Histaminergic Pathways and Overlap with Autism , 2012, Biological Psychiatry.

[2]  Susanne Walitza,et al.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder , 2011, Nature Genetics.

[3]  A. Silahtaroglu,et al.  A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA) , 2011, Epilepsia.

[4]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[5]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse , 2011, Nucleic Acids Res..

[6]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[7]  Wendell A. Lim,et al.  Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information , 2011, Science.

[8]  J. Lacaille,et al.  De Novo SYNGAP1 Mutations in Nonsyndromic Intellectual Disability and Autism , 2011, Biological Psychiatry.

[9]  P. Visscher,et al.  Clustered Coding Variants in the Glutamate Receptor Complexes of Individuals with Schizophrenia and Bipolar Disorder , 2011, PloS one.

[10]  R. Huganir,et al.  Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. , 2011, American journal of human genetics.

[11]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[12]  Kristina D. Micheva,et al.  Single-Synapse Analysis of a Diverse Synapse Population: Proteomic Imaging Methods and Markers , 2010, Neuron.

[13]  H. Ropers,et al.  Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes , 2010, Nature Genetics.

[14]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[15]  Ute Moog,et al.  Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation , 2010, Nature Genetics.

[16]  S. Mundlos,et al.  The Human Phenotype Ontology , 2010, Clinical genetics.

[17]  J. Lupski,et al.  Genomic and clinical characteristics of microduplications in chromosome 17 , 2010, American journal of medical genetics. Part A.

[18]  S. Grant,et al.  The origin and evolution of synapses , 2009, Nature Reviews Neuroscience.

[19]  S. Grant,et al.  Neuroproteomics: understanding the molecular organization and complexity of the brain , 2009, Nature Reviews Neuroscience.

[20]  S. Grant,et al.  Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins , 2009, Molecular systems biology.

[21]  S. Swamy,et al.  Neurotransmitters Drive Combinatorial Multistate Postsynaptic Density Networks , 2009, Science Signaling.

[22]  S. Grant,et al.  Opposing effects of PSD‐93 and PSD‐95 on long‐term potentiation and spike timing‐dependent plasticity , 2008, The Journal of physiology.

[23]  Richard D Emes,et al.  Evolutionary expansion and anatomical specialization of synapse proteome complexity , 2008, Nature Neuroscience.

[24]  S. Grant,et al.  A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability , 2007, Nature Neuroscience.

[25]  J. Ainge,et al.  Synapse-Associated Protein 102/dlgh3 Couples the NMDA Receptor to Specific Plasticity Pathways and Learning Strategies , 2007, The Journal of Neuroscience.

[26]  Allan R. Jones,et al.  Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.

[27]  D. Blackwood,et al.  Candidate psychiatric illness genes identified in patients with pericentric inversions of chromosome 18 , 2005, Psychiatric genetics.

[28]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[29]  S. J. Martin,et al.  SynGAP Regulates ERK/MAPK Signaling, Synaptic Plasticity, and Learning in the Complex with Postsynaptic Density 95 and NMDA Receptor , 2002, The Journal of Neuroscience.

[30]  S. Grant,et al.  Isolation of 2000‐kDa complexes of N‐methyl‐d‐aspartate receptor and postsynaptic density 95 from mouse brain , 2001, Journal of neurochemistry.

[31]  S. Grant,et al.  Proteomic analysis of NMDA receptor–adhesion protein signaling complexes , 2000, Nature Neuroscience.

[32]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit , 1995, Nature.

[33]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[34]  Alcino J. Silva,et al.  Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. , 1992, Science.

[35]  S. Grant,et al.  Characterization of the proteome, diseases and evolution of the human postsynaptic density , 2011, Nature Neuroscience.

[36]  S. Jamain,et al.  Neuroligin 2 is exclusively localized to inhibitory synapses. , 2004, European journal of cell biology.

[37]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. , 1995, Nature.